🇺🇸 FDA

Company profile · Sponsor

AstraZeneca

EF4A9ED · EMA pharma EU
Pipeline
4
Drugs
0
Patents
0

Quick answer

AstraZeneca (EF4A9ED) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EF4A9ED
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (4)

Search pipeline →

  1. IMFINZI 50 mg/mL concentrate for solution for infusion.

    AstraZeneca

    small cell lung cancer

    phase 3 small molecule active

    1 trial

  2. TRUQAP 160 mg film-coated tablets, TRUQAP 200 mg film-coated tablets

    AstraZeneca

    HR+ / HER2- advanced breast cancer

    phase 3 small molecule active

    1 trial

  3. Calquence 100 mg film-coated tablets

    AstraZeneca

    mantle cell lymphoma (MCL)

    phase 2 small molecule active

    1 trial

  4. IMFINZI 50 mg/mL concentrate for solution for infusion., Lynparza 100 mg film-coated tablets, Lynparza 150 mg film-coated tablets

    AstraZeneca

    Advanced or recurrent endometrial cancer

    approved small molecule active

    1 trial

Frequently asked questions

What is AstraZeneca?

AstraZeneca (EF4A9ED) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does AstraZeneca sponsor?

We track 4 ClinicalTrials.gov-linked programs for AstraZeneca, including IMFINZI 50 mg/mL concentrate for solution for infusion. and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does AstraZeneca company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.